BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3660401)

  • 1. Characteristics of anti-TSH receptor antibodies in two patients who developed spontaneous hypothyroidism after antithyroid drug therapy for hyperthyroid Graves' disease.
    Kaise K; Kaise N; Yoshida K; Itagaki Y; Yamamoto M; Sakurada T; Saito S; Yoshinaga K
    Tohoku J Exp Med; 1987 Jul; 152(3):269-75. PubMed ID: 3660401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on monoclonal antibodies to TSH receptors--heterogeneity and pathophysiological significance of antibodies to TSH receptor].
    Yoshida T
    Nihon Naibunpi Gakkai Zasshi; 1986 Dec; 62(12):1384-99. PubMed ID: 3817231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
    Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
    J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Graves' disease patients who spontaneously developed hypothyroidism after antithyroid drug treatment: characteristics of epitopes for thyrotropin receptor antibodies.
    Chung HK; Kim WB; Park DJ; Kohn LD; Tahara K; Cho BY
    Thyroid; 1999 Apr; 9(4):393-9. PubMed ID: 10319947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment.
    Tamai H; Hirota Y; Kasagi K; Matsubayashi S; Kuma K; Iida Y; Konishi J; Okimura MC; Walter RM; Kumagai LF
    J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible primary hypothyroidism with blocking or stimulating type TSH binding inhibitor immunoglobulin following recombinant interferon-alpha therapy in patients with pre-existing thyroid disorders.
    Chen FQ; Okamura K; Sato K; Kuroda T; Mizokami T; Fujikawa M; Tsuji H; Okamura S; Fujishima M
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):207-14. PubMed ID: 8881454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-TSH antibodies in Graves' disease and their failure to interact with TSH receptor antibodies.
    Ochi Y; Nagamune T; Nakajima Y; Ishida M; Kajita Y; Hachiya T; Ogura H
    Acta Endocrinol (Copenh); 1989 Jun; 120(6):773-7. PubMed ID: 2567103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthyroidism following hypothyroidism.
    McDermott MT; Kidd GS; Dodson LE; Hofeldt FD
    Am J Med Sci; 1986 Mar; 291(3):194-8. PubMed ID: 3006488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperthyroid Graves' disease and primary hypothyroidism caused by TSH receptor antibodies in monozygotic twins: case reports.
    Tani J; Yoshida K; Fukazawa H; Kiso Y; Sayama N; Mori K; Aizawa Y; Hori H; Nakasato N; Abe K
    Endocr J; 1998 Feb; 45(1):117-21. PubMed ID: 9625455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on the thyrotropin receptor and adenylate cyclase activity in various thyroid diseases: I. The properties of TSH receptor and adenylate cyclase in Graves' thyroid and retro-orbital adipose tissues (author's transl)].
    Abe Y
    Nihon Naibunpi Gakkai Zasshi; 1980 May; 56(5):739-53. PubMed ID: 6248386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to the thyrotropin receptor.
    Rees Smith B; McLachlan SM; Furmaniak J
    Endocr Rev; 1988 Feb; 9(1):106-21. PubMed ID: 3286231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
    Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroidal drugs: clinical, immunological, and histological findings in 26 patients.
    Tamai H; Kasagi K; Takaichi Y; Takamatsu J; Komaki G; Matsubayashi S; Konishi J; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1989 Jul; 69(1):49-53. PubMed ID: 2471711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence against the importance in the disease process of antibodies to bovine thyroid-stimulating hormone found in some patients with Graves' disease.
    Noh J; Hamada N; Saito H; Oyanagi H; Ishikawa N; Momotani N; Ito K; Morii H
    J Clin Endocrinol Metab; 1989 Jan; 68(1):107-13. PubMed ID: 2909548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking type antithyrotropin receptor antibody in patients with nongoitrous hypothyroidism: its incidence and characteristics of action.
    Arikawa K; Ichikawa Y; Yoshida T; Shinozawa T; Homma M; Momotani N; Ito K
    J Clin Endocrinol Metab; 1985 May; 60(5):953-9. PubMed ID: 2858492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of thyrotropin-stimulated adenylate cyclase activation and growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema: comparison with activities of thyrotropin-binding inhibitor immunoglobulins.
    Cho BY; Shong YK; Lee HK; Koh CS; Min HK
    Acta Endocrinol (Copenh); 1989 Jan; 120(1):99-106. PubMed ID: 2563181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin receptor non-mediated thyroid stimulating immunoglobulin in Graves' disease.
    Endo T; Haraguchi K; Ohmori M; Ikeda M; Ohta K; Onaya T
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1543-7. PubMed ID: 1656957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.